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Introduction: Since the introduction and widespread acceptance of percutaneous techniques in the intensive care
unit (ICU) setting, the number of critically ill patients undergoing tracheostomy has steadily increased. However, this
procedure can be associated with major complications, including death. The purpose of this study is to estimate
the incidence and analyze the causes of lethal complications due to percutaneous dilatational tracheostomy (PDT).
Methods: We analyzed cases of lethal outcome due to complications from PDT including cases published between
1985 and April 2013. A systematic literature search was performed and unpublished cases from our own
departmental records were retrospectively analyzed.
Results: A total of 71 cases of lethal outcome following PDT were identified including 68 published cases and 3 of
our own patients. The incidence of lethal complications was calculated to be 0.17%. Of the fatal complications,
31.0% occurred during the procedure and 49.3% within seven days of the procedure. The main causes of death
were: hemorrhage (38.0%), airway complications (29.6%), tracheal perforation (15.5%), and pneumothorax (5.6%). We
found specific risk factors for complications in 73.2% of patients, 25.4% of patients had more than one risk factor.
Bronchoscopic guidance was used in only 46.5% of cases.
Conclusions: According to this analysis, PDT-related death occurs in 1 out of 600 patients receiving a PDT. Careful
patient selection, bronchoscopic guidance, and securing the tracheal cannula with sutures are likely to reduce
complication rates.Introduction
Since the introduction and widespread acceptance of
percutaneous techniques in the intensive care unit (ICU)
setting, the number of critically ill patients undergoing
tracheostomy has increased in recent years [1,2]. Given a
predicted increase in the numbers of mechanically venti-
lated patients, a further increase in the number of trache-
ostomy procedures in the ICU is to be expected [1-4].
The ideal timing of tracheostomy is still a subject of
debate as there is no clear evidence that early tracheos-
tomy improves relevant endpoints, such as duration of
mechanical ventilation, length of ICU stay, and mortality* Correspondence: s.kluge@uke.de
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reproduction in any medium, provided the or[5]. Nevertheless, tracheostomy is being undertaken sig-
nificantly earlier during ICU stay, as the intervention
appears to be beneficial in terms of patient comfort,
mobility, and reducing the requirement for sedation [1,6].
Percutaneous dilatational tracheostomy (PDT) has gained
wide acceptance and has become the procedure of choice
for tracheostomy in critically ill patients worldwide [7].
However this procedure, just like surgical tracheostomy, is
associated with major complications, including death. It is
estimated that each year approximately 500 patients in the
United States die or are permanently disabled because of a
tracheostomy [8].
Three fatalities due to PDT in our department in recent
years prompted us to perform this study. We aimed to
analyze cases from the literature and from our own data-
base to determine the incidence of lethal complications
due to percutaneous tracheostomy, to reveal the causes of
death, to identify risk factors and possible mechanisms forLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tions to further minimize the risks of complication.
Materials and methods
The study was conducted and reported according to
PRISMA guidelines [9].
Search strategy
A systematic search for articles was performed in PubMed,
Embase and the Cochrane Library without restrictions for
language searching for case reports, case series, observa-
tional studies and randomized trials describing or including
fatalities associated with PDT. We focused on studies pub-
lished from 1985 onward as the percutaneous approach
gained popularity after its description by Ciaglia et al. [10]
in that specific year.
An extensive and sensitive search strategy was chosen
using the keywords ‘percutaneous tracheostomy’ and
‘percutaneous tracheotomy’ to ensure comprehensive re-
trieval of articles. The search was last updated on 30
April 2013.
Study selection
Studies were selected independently by two authors (MS
and SK). Disagreements between the two authors were
resolved by discussion. The titles and abstracts of all publi-
cations retrieved by the search strategy were screened for
eligibility. Studies on PDT were selected for further evalu-
ation. Full-text review of these studies was performed.
Studies were included if one or more PDT-related deaths
were described. In addition, the reference sections of all
studies on PDT were handsearched for additional relevant
publications.
Data extraction, assessment, completion and synthesis
Data was independently extracted with standardized
forms and interpreted by three authors (MS, SB, SK).
The results of data extraction were then compared and
disagreement resolved by discussion. Included publica-
tions were reviewed manually for relevant data. Informa-
tion concerning patient characteristics (age, gender, main
diagnosis, and duration of mechanical ventilation before
tracheostomy), tracheostomy procedure (technique, bron-
choscopic guidance, pre-interventional ultrasound, per-
forming physician or team, procedure-related difficulties,
special circumstances, and risk factors for complications),
cause and time of death as well as departmental character-
istics (type of ICU, year of introduction of PDT in the de-
partment, number of PDTs performed annually and the
number of fatalities related to PDT since its introduction
in the department) was extracted. If the published data set
was incomplete, we contacted the corresponding author
via email or post. If the corresponding author did not
respond within four weeks, we sent a reminder.Retrieval of PDT-related fatalities from our own department
To identify tracheostomy-related fatalities in our own
department, all patients who had undergone PDT be-
tween 1 January 2005 and 31 December 2012 were iden-
tified from the departmental electronic patient database.
Cases retrieved from this search were further evaluated
for procedure-related deaths by manual analysis of their
medical records.
Since 1st January 2005, the Ciaglia Blue Rhino™ tech-
nique assisted by bronchoscopic guidance has been the
standard technique for PDT in our department. The
PDTs were performed at the bedside in one of the 10 de-
partmental ICUs according to a standardized operating
procedure [11]. After completion, a protocol document-
ing key aspects of the procedure was generated and
saved in the electronic medical record.
The ethics committee of the Hamburg Chamber of
Physicians and the institutional data protection official
approved the collection, analysis, and publication of the
retrospectively obtained and anonymized data for this
noninterventional study.
Data analysis
Results are presented as medians and ranges or as abso-
lute numbers with percentages. The software used for
descriptive analyses was Microsoft Excel 2011 (Microsoft
Corp., Redmond, WA, USA).
Results
Study and case selection
The search strategy yielded a total of 1,963 articles.
From these publications 45 studies describing 65 PDT-
related fatalities were included in the study. Three more
cases could be added from personal communication with
the corresponding authors. Three additional cases were
included from our own departmental records. Overall,
71 cases of PDT-related death were included and ana-
lyzed in this study. The process of case selection is sum-
marized in Figure 1.
By contacting the corresponding authors, case spe-
cific data could be added in 20 cases and departmental
data concerning the total numbers of PDT procedures
and PDT-related fatalities could be obtained from 17
departments.
Study characteristics
We found sixteen case reports or case series, seven
retrospective studies, twenty prospective observational
studies and two randomized trials. Study characteristics
are summarized in Table 1.
Summary and analysis of all cases
The median age was 66 years (range 4 to 95). For further
details concerning patient characteristics see Table 2.
Figure 1 Process of case selection. *[12-14]. **[15,16].
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(45.1%) and the Ciaglia Blue Rhino™ (26.8%) technique.
Bronchoscopic guidance was used in 46.5% of cases, but
no cases involved pre- or peri-interventional ultrasound.
The major causes of death were tracheostomy-related
hemorrhage in 27 patients (38.0%) and airway complica-
tions in 21 patients (29.6%). In 31.0% of cases, fatal com-
plications occurred during the procedure and in 49.3%
of cases within seven days of the procedure. 73.2% of pa-
tients had specific risk factors and 25.4% of patients had
more than one risk factor. For further details about the
causes of death and time of complications see Table 3.
Hemorrhage
We found 27 deaths (38.0%) due to hemorrhage [18,19,
22-26,28-31,35,37,39,43,46,49,54,57-59]. The source of
bleeding was arterial in 16 cases (59.3%). Most often
arterial bleeding originated from tracheovascular fistula
formation involving the innominate artery (11 cases).
The majority of bleeding incidents (75.0%) occurred be-
tween one day and one month after the tracheostomy pro-
cedure, with a median of five days. The following known
risk factors were retrospectively attributed as potentially
relevant in these fatalities secondary to hemorrhagic com-
plications: not using bronchoscopic guidance (eight cases),
low tracheostomy site (five cases), coagulopathy (five
cases), previous surgery to the neck (four cases), previousradiotherapy (one case), obesity (one case), anatomical
abnormality (one case), paratracheal misplacement of the
tracheal cannula (one case), malpositioned cannula tip
(one case), and high cuff pressure (one case). Twenty-one
patients (77.8%) had at least one of the described risk
factors.
Airway complications
Twenty-one deaths (29.6%) due to airway complications
were reported [32,34,38-40,42,44,48,50-53,56,60,61]. Main
causes of death in this group were dislocation of the tra-
cheal cannula (52.4%), lost airway during the procedure
(19.0%) and paratracheal misplacement of the tracheal
cannula (14.3%). Performing the procedure without bron-
choscopic guidance (six cases), by a team relatively in-
experienced with the procedure (five cases), in obese
patients (eight cases), in patients with a difficult airway
(two cases), not securing the tracheal cannula with su-
tures (three cases), early cannula replacement (one case),
and post-procedural care by an inexperienced team (one
case) were determined as risk factors for these fatalities at-
tributed to airway complications. Nineteen patients (90.5%)
had at least one of the described risk factors.
Tracheal perforation
Including our own cases, a total of 11 deaths (15.5%)
were due to tracheal perforation [17,20,47,49,53,57,59].
Table 1 Characteristics of studies included
Study Departmental data obtained by personal communication
with the corresponding author












Byhahn [16] CR 2
Cobean [15] CR 1
Hutchinson [17] 1991 CR 1
Cokis [18] 2000 CR 1
Hürter [19] 2000 CR Surgical 1 252 2 0.79
Drage [20] 2002 CR 1
Maeda [21] 2002 CR Mixed 1
Soubirou [22] 2002 CR Surgical 1
Ryan [23] 2003 CR 1
Shlugman [24] 2003 CR Neurological 1 700 1 0.14
McCormick [25] 2005 CR Mixed 3 2,100 4 0.19
Grant [26] 2006 CR Mixed 3
Rosolski [27] 2006 CR Mixed 1 420 1 0.24
Ayoub [28] 2007 CR 1
Zehlicke [29] 2007 CR 1
Wang [30] 2009 CR 1
Hoiting [31] 2010 CR 2
Gilbey [32] 2012 CR Mixed 1 420 1 0.24
Ivatury [33] 1992 RS 61 1 1.64
Cobean [34] 1996 RS Mixed 65 1 1.54 1,080 2 0.19
van Heurn [35] 1996 RS Mixed 150 1 0.67 880 1 0.11
Thompson [36] 2001 RS Medical 300 1 0.33
Pandit [37] 2006 RS Mixed 501 1 0.20 1,265 2 0.16
Klein [38] 2007 RS Mixed 207 1 0.48
Dennis [39] 2013 RS 3162 5 0.16 3,162 5 0.16
Toye [40] 1986 POS 94 1 1.06
Marelli [41] 1990 POS 61 1 1.64
Wang [42] 1992 POS Surgical 7 1 14.29
Friedman [43] 1993 POS 100 1 1.00
Cole [44] 1994 POS 55 1 1.82
Barba [45] 1995 POS Surgical 27 1 3.70
Muhl [46] 1995 POS Surgical 14 1 7.14 720 1 0.14
Joosten [47] 1996 POS Surgical 53 1 1.89 420 1 0.24
Marx [48] 1996 POS 254 1 0.39
Berrouschot [49] 1997 POS Neurological 76 2 2.63 900 2 0.22
Walz [50] 1998 POS 337 2 0.59
Suh [51] 1999 POS 95 2 2.11 1,040 2 0.19
Escarment [52] 2000 POS 162 2 1.23
Kearney [53] 2000 POS Mixed 827 5 0.60 5,400 9 0.17
Lim [54] 2000 POS 261 2 0.77
Norwood [55] 2000 POS 422 1 0.24
Tan [56] 2004 POS 352 1 0.28
Byhahn [57] 2005 POS Surgical 474 2 0.42 2,775 4 0.14
Chiu [58] 2005 POS Medical 107 1 0.93 900 1 0.11
Simon et al. Critical Care 2013, 17:R258 Page 4 of 9
http://ccforum.com/content/17/5/R258
Table 1 Characteristics of studies included (Continued)
Páez [59] 2005 POS 38 2 5.26
Porter [60] 1999 RT Surgical 12 1 8.33
Massick [61] 2001 RT Medical 50 1 2.00
Own cases Mixed 3 1,873 3 0.16
Summary 8324 71 2.18* 24,307 42 0.17
*Calculated mean mortality rate including data from retrospective studies, prospective observational studies and randomized trials. CR, case report, RS, retrospective study,
POS, prospective observational study, RT, randomized trial.
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(five cases), by an inexperienced team (four cases), in an
obese patient (one case), in a child (one case), noticing a
kinking of the guidewire postprocedurally (two cases),
and anatomic abnormalities of the spine (one case) were
determined as risk factors for this kind of complication.
Nine patients (81.8%) had at least one of the described
risk factors.
Pneumothorax
Four deaths (5.6%) resulting from a pneumothorax were
reported [15,27,36,55]. Two deaths were due to tension
pneumothoraces and two were due to bilateral pneumo-
thorax. Primary symptoms were subcutaneous emphysemaTable 2 Patient characteristics
Characteristic Values
Number of patients 71




not specified 22 (31.0%)
Main diagnosis
pulmonary disease 15 (21.1%)
neurologic disease 18 (25.4%)
trauma 9 (12.7%)
cardiac disease 5 (7.0%)
surgical procedure 4 (5.6%)
vascular disease 3 (4.2%)
not specified 17 (23.9%)







not specified 30 (42.3%)
Median duration of intubation before
tracheostomy (days)
11 (range 0-33)and/or hypoxemia. Chronic obstructive pulmonary disease
(three cases) was stated as underlying condition putting pa-
tients at risk for this type of complication.
Bronchospasm
Three deaths (4.4%) due to bronchospasm were reported
[33,45,53]. Severe acute respiratory distress syndrome
(ARDS) (two cases) and chronic obstructive pulmonary
disease (one case) were stated as underlying conditions
putting patients at risk for this type of complication.
Cardiac arrest/arrhythmia
Three intraprocedural deaths (4.4%) due to cardiac arrest
were reported [41,50,57]. Cardiac disease and surgery to
the heart were recognized as underlying conditions putting
patients at risk for this type of complication.
Sepsis
One death (1.5%) was due to sepsis [21]. Sepsis was due
to mediastinitis originating from the tracheostomy site.
Previous sternotomy performed for the treatment of an
aneurysm of the thoracic aorta was identified as a risk
factor.
Mortality rate
The mean mortality rate calculated from retrospective
studies, prospective observational studies and random-
ized trials included in this study and overlooking 8,324
PDT procedures was 2.18%.
Departmental data could be obtained from 17 depart-
ments responsible for a total number of 24,307 PDT
procedures and 42 fatalities. The incidence of death at-
tributable to PDT calculated from these numbers was
0.17%.
In our own department 1,873 patients underwent PDT
between 1 January 2005 and 31 December 2012 and three
procedure-related fatalities occurred resulting in an inci-
dence of PDT-related lethal complications of 0.16%.
Discussion
We analyzed 71 cases of death due to PDT. The inci-
dence of death related to PDT calculated from depart-
mental data provided by corresponding authors was
0.17%, which is in line with the lethal complication rate
Table 3 Causes and time of death after PDT
Cause of death Total number Time of death
Intra-procedural Post-procedural
Total number 71 22 (31.0%) 49 (69.0%)
Hemorrhage 27 (38.0%) 3 (11.1%) 24 (88.9%)
- innominate artery 11 (40.7%) 11 (100.0%)
- aortic arch 2 (7.4%) 2 (100.0%)
- subclavian artery 1 (3.7%) 1 (100.0%)
- thyroid artery 1 (3.7%) 1 (100.0%)
- other artery 1 (3.7%) 1 (100.0%)
- venous 5 (18.5%) 1 (20.0%) 4 (80.0%)
- diffuse/unknown 6 (22.2%) 6 (100.0%)
Airway complications 21 (29.6%) 7 (33.3%) 14 (66.7%)
- dislocation of the tracheal cannula 11 (52.4%) 1 (9.1%) 10 (90.9%)
- lost airway during the procedure 4 (19.0%) 3 (75.0%) 1 (25.0%)
- paratracheal misplacement of the tracheal cannula 3 (14.3%) 3 (100.0%)
- obstruction of tracheal cannula 2 (9.5%) 2 (100.0%)
- hypoxemia during cannula replacement 1 (4.8%) 1 (100.0%)
Tracheal perforation 11 (15.5%) 1 (9.1%) 10 (90.9%)
Pneumothorax 4 (5.6%) 4 (100.0%)
Bronchospasm 3 (4.2%) 3 (100.0%)
Cardiac arrest/arrhythmia 3 (4.2%) 3 (100.0%)
Sepsis 1 (1.4%) 1 (100.0%)
Unknown 1 (1.4%) 1 (100.0%)
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strophic events resulting in death were vascular injuries
and airway complications. We found specific risk factors
in 73.2% of patients, and 25.4% of patients had more
than one risk factor. To the best of our knowledge this
is the first systematic analysis of lethal complications
due to PDT.
Gilbey et al. recently published a case series of fatal
cases due to PDT and concluded that this event usually
results from vascular injury [32]. However, their report
included only seven cases, without providing further in-
formation about demographics, PDT technique, use of
bronchoscopy or ultrasound.
Even after surgical tracheostomy, fatal complications
can occur. In a survey of members of the American
Academy of Otolaryngology, Head and Neck Surgery
two-thirds of (mainly surgical) tracheostomy-related cata-
strophic events were reported to be mainly due to loss of
airway or bleeding [8].
Tracheostomy-related hemorrhage was the most com-
mon cause of death in our study. Massive hemorrhage is
a rare but devastating complication after any form of
tracheostomy and usually originates from tracheoarterial
fistula formation. The majority of cases occur within three
days to six weeks of tracheostomy, and risk factors include
pressure necrosis from high cuff pressure, mucosal trauma,malpositioned cannula tip, low tracheal incision, excessive
neck movement, radiotherapy, or prolonged intubation
[26]. We found such risk factors in 77.8% of these patients.
In 29.6% of studied patients with fatal bleeding, performing
the procedure without bronchoscopy was determined as a
risk factor. In this group, placement of tracheostomy was
too low in five patients, of which two had an aortic arch
laceration. Coagulation dysfunction or platelet dysfunction
were present in five patients. These were not deemed to
be the primary cause of bleeding in two cases as these pa-
tients died from acute and sudden bleeding from specific
blood vessels and without diffuse bleeding. Indeed, it
has been shown previously, that even in severe thrombo-
cytopenia, PDT can be safely performed after preproce-
dural correction [62].
A major risk factor seems to be a low tracheal incision,
as was the case in five of twenty-seven patients with
bleeding complications in our study. The site of punc-
ture should ideally be selected between first and second
or second and third tracheal rings [63]. In one study, the
site of tracheal puncture was changed in 24% of patients
as a result of prior ultrasound [64]. Furthermore, preproce-
dural ultrasound and clinical examination have been used
to detect abnormal pretracheal vascular anatomy. There-
fore, several authors recommend ultrasound to improve
the safety of PDT [64-67].
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complications. The tracheal cannula was placed outside
the tracheal lumen in three cases. Of note, in all of these
cases bronchoscopic guidance was not used. Despite the
lack of randomized controlled trials many authors think
that the use of bronchoscopic guidance significantly in-
creases the safety of PDT as it can guide correct place-
ment of the introducer needle, the guidewire, and the
cannula during the procedure [68,69].
In a further 11 patients, the tracheal cannula acciden-
tally dislocated postprocedurally. While the surgical ap-
proach allows easy reinsertion of the tracheal cannula,
airway complications such as accidental decannulation
or tube obstruction are well-described problems of the
percutaneous technique [70]. Some researchers have
proposed that fixing the tracheal cannula to the skin
with sutures for the first postprocedural week may de-
crease cannula-related complications such as accidental
decannulation and postoperative bleeding [71,72].
In two of the eleven deaths (18.2%) due to posterior
tracheal wall perforation, kinking of the guidewire was
noticed after its removal during the procedure. Other re-
searchers have postulated guidewire kinking as a pos-
sible mechanism for perforation of the posterior tracheal
wall [73,74]. Thus, kinking of the guidewire must be
avoided and its occurrence should raise suspicion of po-
tential injury to the posterior tracheal wall prompting
further investigation.
To avoid complications, PDT should only be consid-
ered in selected patients without contraindications. Con-
traindications to PDT include anatomic distortion of the
neck, the presence of a difficult airway, severe ARDS,
uncorrectable coagulopathy, and the presence of an un-
stable cervical spine [68]. However, most of these contra-
indications are relative and also dependent on the skill of
the operator. Of the ten cases (14.1%) in our study, where
the performing team was deemed to be relatively in-
experienced in the procedure, contraindications were also
present in two patients (20.0%).
Because of the growing numbers of patients requiring
ventilatory support, the frequency of tracheostomy in
the ICU has increased over the last decades as has the
number of PDT-related publications (Additional file 1).
In addition, it is conceivable that after the introduction
and widespread acceptance of percutaneous techniques,
enthusiasm about the ease of performing this procedure
at the bedside may have resulted in relative overuse by
intensivists.
A general limitation of this systematic review is the
possibility of under- or over-estimating the true inci-
dence of PDT-related death. Accurate risk assessment in
clinical medicine is most difficult when an event is rare
and available evidence is based on self-reported data [75].
Additionally, concerning the topic of this study, there issometimes considerable difficulty in differentiating whether
an adverse event is due to being critically ill with a trache-
ostomy or whether it is a complication of the PDT proced-
ure itself. However, in all cases included in this study, the
authors of the original publications judged death to be
most likely related to the PDT procedure itself. Calculated
from departmental data provided by the corresponding
authors - where we are confident of both the complete-
ness of reporting and the denominator - the mortality rate
from PDT was 0.17%. This is very much in line with the
mortality rate of 0.16% reported in the largest study pub-
lished to date [39] and the mortality rate of 0.16% in our
own institution.
In our opinion, this first systemic analysis of the inci-
dence and causes of PDT-related lethal complications
adds important evidence to the literature and serves to
remind clinicians about potentially life-threatening com-
plications and to help them minimize risk factors by
choosing suitable patients and safe procedural strategies.Conclusions
In conclusion, PDTs, which are frequently performed in
ICUs worldwide, are associated with an average mortality
of one in every six hundred procedures. Major risk factors
are present in a substantial proportion of these patients.
To prevent severe complications, the results of this system-
atic review, several authors and professional guidelines sug-
gest that the following measures may improve the safety of
PDT: strict consideration of contraindications, broncho-
scopic guidance during the entire procedure, performance
by an experienced team, avoidance of a low tracheostomy
puncture site and avoidance of guidewire kinking as well as
the use of outer flange tracheal cannula sutures.Key messages
 PDT-related death occurs in one out of six hundred
procedures.
 Careful patient selection, bronchoscopic guidance,
and securing the tracheal cannula with sutures are
likely to reduce complication rates.Additional file
Additional file 1: Number of publications reporting PDT-related fa-
talities and total number of publications on PDT procedures.Abbreviations
ARDS: Acute respiratory distress syndrome; ICU: Intensive care unit;
PDT: Percutaneous dilatational tracheostomy.
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